Zhang; Shuyi

Patent Applications and Registrations

Patent applications and USPTO patent grants for Zhang; Shuyi.The latest application filed is for "methods for enhancing selectivity in sam-based selective deposition".

Company Profile

2.12.14

Zhang; Shuyi - Santa Clara CA
Zhang; Shuyi - San Jose CA
Zhang; Shuyi - Boston MA
ZHANG; Shuyi - Shanghai CN
Zhang; Shuyi - Nanjing N/A CN
Zhang; Shuyi - Parsippany NJ
Zhang; Shuyi - Parsipanny NJ
Zhang; Shuyi - Parispanny NJ

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Centralized platform for enhanced automated machine learning using disparate datasets Grant 11,443,237 - Song , et al. September 13, 2	2022-09-13
Methods For Enhancing Selectivity In Sam-Based Selective Deposition App 20210217615 - Ke; Chang ; et al.	2021-07-15
Engineered Dcas9 With Reduced Toxicity And Its Use In Genetic Circuits App 20210079404 - Voigt; Christopher A. ; et al.	2021-03-18
Methods for enhancing selectivity in SAM-based selective deposition Grant 10,950,433 - Ke , et al. March 16, 2	2021-03-16
Engineered Dcas9 With Reduced Toxicity And Its Use In Genetic Circuits App 20200095589 - Voigt; Christopher A. ; et al.	2020-03-26
Methods for Enhancing Selectivity in SAM-Based Selective Deposition App 20190157079 - Ke; Chang ; et al.	2019-05-23
Method And System For Communication Devices App 20160226930 - ZHANG; Shuyi ; et al.	2016-08-04
Multi-mode interferometer techniques Grant 9,116,300 - Lu , et al. August 25, 2	2015-08-25
Process and intermediates for the synthesis of 1,2-substituted 3,4-dioxo-1-cyclobutene compounds Grant 8,519,168 - Fu , et al. August 27, 2	2013-08-27
Multi-mode Interferometer Techniques App 20120224806 - Lu; Yanqing ; et al.	2012-09-06
Crystalline polymorphs of a CXC-chemokine receptor ligand Grant 8,207,221 - Hu , et al. June 26, 2	2012-06-26
Process and intermediates for the synthesis of 2-(quinolin-5-yl)-4,5 disubstituted-azole derivatives Grant 7,985,860 - Cutarelli , et al. July 26, 2	2011-07-26
Synthesis of 2-Hydroxy-N,N-dimethyl-3-[[2-[[1(R)-(5-methyl-2-furanyl)propyl]amino]-3,4- -dioxo-1-cyclobuten-1-yl]amino]benzamide Grant 7,910,775 - Yin , et al. March 22, 2	2011-03-22
Sustained release formulations containing acetaminophen and tramadol App 20090162431 - Zhang; Shuyi ; et al.	2009-06-25
Synthesis Of 2-hydroxy-n,n-dimethyl-3-[[2-[[1(r)-(5-methyl-2-furanyl)propyl]amino]-3,4- -dioxo-1-cyclobuten-1-yl]amino]benzamide App 20090048458 - Yin; Jianguo ; et al.	2009-02-19
Synthesis of 2-hydroxy-n,n-dimethyl-3-[[2-[[1(r)-(5-methyl-2-furanyl)propyl]amino]-3,4- -dioxo-1-cyclobuten-1-yl]amino]benzamide Grant 7,462,740 - Yin , et al. December 9, 2	2008-12-09
Crystalline Polymorphs of a CXC-Chemokine Receptor Ligand App 20080279822 - Hu; Mengwei ; et al.	2008-11-13
Sustained release formulations containing acetaminophen and tramadol Grant 7,374,781 - Zhang , et al. May 20, 2	2008-05-20
Process and intermediates for the synthesis of 2-(quinolin-5-yl)-4,5 disubstituted-azole derivatives App 20080045718 - Cutarelli; Timothy D. ; et al.	2008-02-21
Synthesis of 2-hydroxy-N,N-dimethyl-3-[[2-(1(R)-(5-methyl-2-furany)propyl]amino]-3,4-d- ioxo-1-cyclobuten-1-yl]amino]benzamide App 20060205961 - Yin; Jianguo ; et al.	2006-09-14
Synthesis of 2-hydroxy-N,N-dimethyl-3-[ [2-[1 (R)-(5-methyl-2-furanyl)propyl]amino]-3,4-dioxo-1-cyclobuten-1-yl]aminobe- nzamide Grant 7,071,342 - Yin , et al. July 4, 2	2006-07-04
Crystalline polymorphs of a CXC-chemokine receptor ligand App 20050192345 - Hu, Mengwei ; et al.	2005-09-01
Synthesis of 2-hydroxy-N,N-dimethyl-3-[[2-[1(R)-(5-methyl-2-furanyl)propyl- ]amino]-3,4-dioxo-1-cyclobuten-1-l]aminobenzamide App 20040209946 - Yin, Jianguo ; et al.	2004-10-21
Sustained release formulations containing acetaminophen and tramadol App 20040131671 - Zhang, Shuyi ; et al.	2004-07-08

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.